Raymond James on AxoGen, Inc. (AXGN): 'PDUFA Timing Pushout Adds Drama, but We Still Expect Approval'

August 25, 2025 11:01 AM EDT Send to a Friend
Raymond James analyst Jayson Bedford reiterated an Outperform rating and $20.00 price target on AxoGen, Inc. (NASDAQ: AXGN).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login